Insmed Incorporated
NASDAQInsmed just delivered the biggest single-day move in its recent history, with shares up 34% Thursday to close at $132.55 — a weekly gain of 31% that appears directly tied to earnings and pipeline data released August 6. The story here is not about short pressure driving the move. It's about a dramatic fundamental re-rating catching a still-retreating short base mid-exit, while the…
Snapshot as of 9 Aug 2026
Insmed just delivered the biggest single-day move in its recent history, with shares up 34% Thursday to close at $132.55 — a weekly gain of 31% that appears directly tied to earnings and pipeline data released August…
Insmed heads into its August earnings window with the most notable story sitting not in options or analyst desks, but in a sharp and sudden retreat of short sellers — even as insiders quietly sell into the rally. Short…
Insmed heads into the July 4 holiday week with an interesting push-pull: shorts have been quietly cutting positions while the stock climbs, yet insiders at the highest levels have been just as steadily selling into the…
Insmed is navigating a rough stretch — a brutal earnings-day selloff, a mounting short position, and a fresh shelf registration filed after the close — all while the Street remains structurally bullish at a price that…
Insmed heads into its May 13 Q1 print carrying a bruise that's hard to ignore: the stock fell 26% in a single session on May 7. That drop — the largest recorded in the earnings history data — came after the company…
Insmed Incorporated enters its May 7 Q1 results with a clear tension at its core: the Street is broadly bullish and price targets sit well above where the stock trades, yet short sellers have been quietly rebuilding…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INSM — free to start on ORTEX.
Sign up for free →Open INSM on ORTEX